Page last updated: 2024-09-04

gadofosveset trisodium and Liver Cirrhosis

gadofosveset trisodium has been researched along with Liver Cirrhosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beuf, O; Leporq, B; Pilleul, F1
Beuf, O; Dumortier, J; Leporq, B; Pilleul, F1

Other Studies

2 other study(ies) available for gadofosveset trisodium and Liver Cirrhosis

ArticleYear
[Perfusion MR imaging of the liver with a vascular contrast agent].
    Journal de radiologie, 2011, Volume: 92, Issue:3

    Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Angiography; Metabolic Clearance Rate; Models, Theoretical; Neovascularization, Pathologic; Organometallic Compounds; Regional Blood Flow; Sensitivity and Specificity

2011
3D-liver perfusion MRI with the MS-325 blood pool agent: a noninvasive protocol to asses liver fibrosis.
    Journal of magnetic resonance imaging : JMRI, 2012, Volume: 35, Issue:6

    Topics: Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Circulation; Liver Cirrhosis; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity

2012